
Glen R. Swann Iii
Examiner (ID: 10193)
| Most Active Art Unit | 2608 |
| Art Unit(s) | 2617, 2736, 2787, 2604, 2608, 3502 |
| Total Applications | 1648 |
| Issued Applications | 1497 |
| Pending Applications | 55 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18754440
[patent_doc_number] => 20230357862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => METHOD FOR PREDICTING IMMUNOTHERAPY RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 18/246456
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246456 | METHOD FOR PREDICTING IMMUNOTHERAPY RESISTANCE | Sep 16, 2021 | Pending |
Array
(
[id] => 18754434
[patent_doc_number] => 20230357854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => ENHANCED SEQUENCING FOLLOWING RANDOM DNA LIGATION AND REPEAT ELEMENT AMPLIFICATION
[patent_app_type] => utility
[patent_app_number] => 18/022861
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022861 | ENHANCED SEQUENCING FOLLOWING RANDOM DNA LIGATION AND REPEAT ELEMENT AMPLIFICATION | Aug 22, 2021 | Abandoned |
Array
(
[id] => 18675690
[patent_doc_number] => 20230313311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHOD OF ASSESSING THE CIRCADIAN RHYTHM OF A SUBJECT HAVING CANCER AND/OR ASSESSING A TIMING OF ADMINISTRATION OF A MEDICAMENT TO SAID SUBJECT HAVING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/023581
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023581 | METHOD OF ASSESSING THE CIRCADIAN RHYTHM OF A SUBJECT HAVING CANCER AND/OR ASSESSING A TIMING OF ADMINISTRATION OF A MEDICAMENT TO SAID SUBJECT HAVING CANCER | Aug 19, 2021 | Pending |
Array
(
[id] => 18628614
[patent_doc_number] => 20230287490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => SYSTEMS AND METHODS FOR ASSAYING A PLURALITY OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/007032
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007032 | SYSTEMS AND METHODS FOR ASSAYING A PLURALITY OF POLYPEPTIDES | Jul 26, 2021 | Pending |
Array
(
[id] => 18567490
[patent_doc_number] => 20230257824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 18/006888
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006888
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | Jul 25, 2021 | Pending |
Array
(
[id] => 17548549
[patent_doc_number] => 20220119890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE
[patent_app_type] => utility
[patent_app_number] => 17/384241
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384241 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Jul 22, 2021 | Pending |
Array
(
[id] => 18740016
[patent_doc_number] => 20230348990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => PROGNOSTIC AND TREATMENT RESPONSE PREDICTIVE METHOD
[patent_app_type] => utility
[patent_app_number] => 18/016942
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016942
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016942 | PROGNOSTIC AND TREATMENT RESPONSE PREDICTIVE METHOD | Jul 19, 2021 | Pending |
Array
(
[id] => 18583251
[patent_doc_number] => 20230265511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => MOLECULAR SIGNATURE OF A COMMON ALOPECIC STATE, ASSOCIATED WITH CELL JUNCTIONS
[patent_app_type] => utility
[patent_app_number] => 18/002270
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002270
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002270 | MOLECULAR SIGNATURE OF A COMMON ALOPECIC STATE, ASSOCIATED WITH CELL JUNCTIONS | Jun 29, 2021 | Pending |
Array
(
[id] => 18597659
[patent_doc_number] => 20230272456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => CASCADING AMPLIFICATION FOR CHEMICAL AND BIOSENSING
[patent_app_type] => utility
[patent_app_number] => 18/008130
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -106
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008130
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008130 | CASCADING AMPLIFICATION FOR CHEMICAL AND BIOSENSING | Jun 2, 2021 | Pending |
Array
(
[id] => 18406155
[patent_doc_number] => 20230167506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => DETECTING PANCREATIC NEUROENDOCRINE TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/921710
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -90
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/921710 | DETECTING PANCREATIC NEUROENDOCRINE TUMORS | May 3, 2021 | Pending |
Array
(
[id] => 17068488
[patent_doc_number] => 20210270703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHOD FOR ISOLATING NUCLEI AND CELLS FROM TISSUES
[patent_app_type] => utility
[patent_app_number] => 17/187096
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187096 | METHOD FOR ISOLATING NUCLEI AND CELLS FROM TISSUES | Feb 25, 2021 | Pending |
Array
(
[id] => 18485344
[patent_doc_number] => 20230212681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => TRANSMEMBRANE NANOSENSOR ARRAYS FOR RAPID, ULTRA-SENSITIVE AND SPECIFIC DIGITAL QUANTIFICATION OF INTERNAL MICRO-RNA CONTENT OF INTACT EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/799755
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799755 | TRANSMEMBRANE NANOSENSOR ARRAYS FOR RAPID, ULTRA-SENSITIVE AND SPECIFIC DIGITAL QUANTIFICATION OF INTERNAL MICRO-RNA CONTENT OF INTACT EXOSOMES | Feb 16, 2021 | Abandoned |
Array
(
[id] => 18295322
[patent_doc_number] => 20230105008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHODS AND COMPOSITIONS FOR IDENTIFYING CASTRATION RESISTANT NEUROENDOCRINE PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/796830
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 442386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -115
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796830 | METHODS AND COMPOSITIONS FOR IDENTIFYING CASTRATION RESISTANT NEUROENDOCRINE PROSTATE CANCER | Feb 7, 2021 | Pending |
Array
(
[id] => 18538728
[patent_doc_number] => 20230243834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 17/793382
[patent_app_country] => US
[patent_app_date] => 2021-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -234
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793382 | COMPOSITIONS AND METHODS FOR DETECTION OF OVARIAN CANCER | Jan 15, 2021 | Pending |
Array
(
[id] => 19746061
[patent_doc_number] => 20250034626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => METHOD OF DETECTING EPIGENETIC MODIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/757847
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757847 | METHOD OF DETECTING EPIGENETIC MODIFICATION | Dec 22, 2020 | Pending |
Array
(
[id] => 18183872
[patent_doc_number] => 20230044602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => CANCER SIGNATURES, METHODS OF GENERATING CANCER SIGNATURES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/786373
[patent_app_country] => US
[patent_app_date] => 2020-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786373 | CANCER SIGNATURES, METHODS OF GENERATING CANCER SIGNATURES, AND USES THEREOF | Dec 19, 2020 | Pending |
Array
(
[id] => 18208329
[patent_doc_number] => 20230054587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Multiplexed Assay Using Differential Fragment Size to Identify Cancer Specific Cell-Free DNA
[patent_app_type] => utility
[patent_app_number] => 17/786969
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786969
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786969 | Multiplexed Assay Using Differential Fragment Size to Identify Cancer Specific Cell-Free DNA | Dec 17, 2020 | Pending |
Array
(
[id] => 18243752
[patent_doc_number] => 20230076063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A MYCOBACTERIUM TUBERCULOSIS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/787114
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787114 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A MYCOBACTERIUM TUBERCULOSIS INFECTION | Dec 17, 2020 | Pending |
Array
(
[id] => 18109952
[patent_doc_number] => 20230002832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => UPPER URINARY TRACT UROTHELIAL CARCINOMA IDENTIFICATION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/780926
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780926 | UPPER URINARY TRACT UROTHELIAL CARCINOMA IDENTIFICATION METHOD | Nov 26, 2020 | Pending |
Array
(
[id] => 18058395
[patent_doc_number] => 20220389481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD FOR DOUBLE STRAND SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/778204
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778204 | METHOD FOR DOUBLE STRAND SEQUENCING | Nov 19, 2020 | Pending |